Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
Efficient selection for high-expression transfectants with a novel eukaryotic vector
1991 • 5,120 citations
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
2001 • 1,678 citations
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
2003 • 1,192 citations
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
2003 • 1,019 citations
Crystal Structure of the Tyrosine Phosphatase SHP-2
1998 • 940 citations
PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum, Genotype-Phenotype Correlation, and Phenotypic Heterogeneity
2002 • 765 citations
Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
2004 • 489 citations
Noonan syndrome: A review
1985 • 455 citations
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
2003 • 429 citations
Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation
2004 • 414 citations
Noonan syndrome.
1987 • 304 citations
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia
2004 • 295 citations
Shp-2 Tyrosine Phosphatase: Signaling One Cell or Many
1999 • 291 citations
Multiple Requirements for SHPTP2 in Epidermal Growth Factor-Mediated Cell Cycle Progression
1996 • 247 citations
Genotype-phenotype correlations in Noonan syndrome
2004 • 245 citations
Noonan syndrome: The changing phenotype
1985 • 244 citations
A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains.
1993 • 219 citations
Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation
2004 • 183 citations
Spectrum of mutations in PTPN11 and genotype–phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome
2003 • 158 citations
Juvenile Myelomonocytic Leukemia and Noonan Syndrome
1999 • 152 citations
PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor
1999 • 142 citations
Activated Mutants of SHP-2 Preferentially Induce Elongation of Xenopus Animal Caps
2000 • 117 citations
Protein-Tyrosine Phosphatase, Nonreceptor Type 11 Mutation Analysis and Clinical Assessment in 45 Patients with Noonan Syndrome
2004 • 112 citations
PTPN11(Protein-Tyrosine Phosphatase, Nonreceptor-Type 11) Mutations in Seven Japanese Patients with Noonan Syndrome
2002 • 112 citations
PTPN11 Mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13
2002 • 87 citations
Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas
2004 • 79 citations
Coordinate Regulation of STAT Signaling and c-fosExpression by the Tyrosine Phosphatase SHP-2
1998 • 62 citations
Insulin-Like Growth Factor System in Neuroblastoma Tumorigenesis and Apoptosis: Potential Diagnostic and Therapeutic Perspectives
1999 • 45 citations
Cas Mediates Transcriptional Activation of the Serum Response Element by Src
1999 • 45 citations
Increased susceptibility to ischemia‐induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2
2000 • 42 citations
PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning
2003 • 32 citations